Product image of Ipratropium Bromide/Salbutamol Neutec (Ipratropium Bromide, Salbutamol) supplied by GNH India

Ipratropium Bromide/Salbutamol Neutec

Active Ingredient:
Ipratropium Bromide, Salbutamol
Origin:
EU

Ipratropium Bromide/Salbutamol Neutec (Ipratropium Bromide, Salbutamol)

Ipratropium bromide, the active ingredient in Ipratropium Bromide/Salbutamol Neutec, is a bronchodilator presented as a combination inhalation solution for inhalation use. It treats bronchospasm associated with chronic obstructive pulmonary disease (COPD), asthma and acute bronchospasm in adult patients.
GNH India supplies Ipratropium Bromide/Salbutamol Neutec as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Neutec Inhaler Ireland Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ipratropium Bromide/Salbutamol Neutec is used in respiratory disorders where airway narrowing occurs.

  • COPD: provides bronchodilation to improve airflow and reduce dyspnea.
  • Asthma: relieves bronchospasm and helps restore normal breathing during acute episodes.
  • Acute bronchospasm: rapidly opens airways to alleviate sudden breathing difficulty.

How It Works

  • Ipratropium bromide acts as a muscarinic antagonist, blocking acetylcholine‑mediated bronchoconstriction, while salbutamol is a short‑acting β2‑adrenergic agonist that stimulates β2 receptors on airway smooth muscle, causing relaxation. The combined effect produces additive bronchodilation, improving airway caliber and airflow in obstructive lung diseases.

Side Effects

Adverse reactions may occur with inhaled ipratropium bromide/salbutamol therapy.

Common Side Effects

  • Throat irritation or cough: mild discomfort in the airway.
  • Tremor or shakiness: usually transient muscle tremor.
  • Headache: mild to moderate intensity.
  • Palpitations: awareness of heartbeat.
  • Dry mouth: reduced salivation.

Serious or Rare Side Effects

  • Paradoxical bronchospasm: worsening airway narrowing.
  • Angioedema or severe allergic reaction: swelling of face, lips, or tongue.
  • Cardiac arrhythmias: abnormal heart rhythm, especially in patients with cardiac disease.
  • Severe tachycardia: rapid heart rate requiring medical attention.
  • Hypersensitivity reactions: rash, urticaria, or anaphylaxis.

Precautions & Warnings

Use of this inhalation product requires careful clinical assessment.

  • Cardiac history: evaluate for existing heart disease before initiating therapy.
  • Monitor for paradoxical bronchospasm: discontinue if breathing worsens.
  • Hypertension: use with caution in patients with high blood pressure.
  • Known hypersensitivity: avoid in individuals allergic to either component.
  • Dosage adherence: do not exceed prescribed frequency or amount.
  • Store at room temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Ipratropium Bromide/Salbutamol Neutec may interact with other medications.

Major Interactions (Avoid)

  • Non‑selective β‑blockers: may diminish bronchodilator effect and precipitate bronchospasm.
  • MAO inhibitors: can increase risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely)

  • Diuretics (e.g., furosemide): may enhance hypokalemia, increasing arrhythmia risk.
  • Theophylline: additive stimulant effect on the heart.
  • Other bronchodilators: may increase incidence of tremor or tachycardia.

Frequently Asked Questions

Ipratropium Bromide/Salbutamol Neutec is indicated for the treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), for relief of acute asthma symptoms, and for managing sudden episodes of acute bronchospasm in adult patients.

Ipratropium bromide blocks muscarinic receptors, preventing acetylcholine‑induced bronchoconstriction, while salbutamol stimulates β2‑adrenergic receptors, causing smooth‑muscle relaxation. Together they provide additive bronchodilation, improving airflow in obstructed airways.

The prescribed dose and frequency are determined by the treating physician based on the patient’s clinical condition, severity of symptoms, and response to therapy. Patients should follow the exact dosing instructions provided on the prescription label.

Safety data for use in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑agent bronchodilators, the combination offers dual mechanisms—anticholinergic and β2‑agonist—resulting in more rapid and sustained airway opening. This can be advantageous over monotherapy in patients who need both quick relief and longer‑lasting bronchodilation.

Store at room temperature: keep the inhalation solution in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed when not in use.

The product is administered by inhalation using a nebulizer or metered‑dose inhaler as directed by the prescriber. Patients should inhale the full dose, hold their breath briefly, and then exhale normally, following the device’s specific instructions.

Serious risks include paradoxical bronchospasm, severe allergic reactions such as angioedema, and cardiac arrhythmias or marked tachycardia, especially in patients with underlying heart disease. Immediate medical attention is required if any of these occur.

Patients with known hypersensitivity to ipratropium bromide, salbutamol, or any excipients in the formulation should avoid this product. It is also contraindicated in individuals who have experienced a severe paradoxical bronchospasm with prior use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ipratropium Bromide, Salbutamol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT